The recommended starting point for finding UK trials is: NIHR Be Part of Research (bepartofresearch.nihr.ac.uk) the UK's public-facing portal for finding and joining clinical research studies ClinicalTrials.gov and the EU Clinical Trials Register international registries of ongoing studies, including the REDEFINE and TRIUMPH programmes Referral via a GP or specialist to a trial centre In the meantime, men with obesity or type 2 diabetes should be aware that NICE-approved treatments are already available and may offer meaningful clinical benefit: Semaglutide (Wegovy) is approved by NICE (TA875) for weight management in adults with a BMI 35 kg/m (or lower thresholds for certain ethnic groups) and at least one weight-related comorbidity, subject to specialist tier service criteria and duration requirements
see FDA Compounded Peptides 2026: What the Crackdown Means for Your Access Only obtain BPC-157 through a licensed Meto provider
Recommended Frequency As occasionally desired, 1x / month, 1x / week, or as often as 2-3x / week To treat symptoms of chronic conditions: 2-3x / week for 6+ weeks, then maintain well-being with an infusion 1x / week or 2-3x / month *Discuss goals and conditions with your provider These statements have not been evaluated by the FDA
You may choose to visit our office for your injections or to administer them yourself at home
Clinically tested
Some published studies have examined co-administration and found additive effects in certain models, though the mechanistic basis for interaction is not fully established